Patient Support Program Helps Sustain Low Disease Activity on TNF Inhibitor Therapy

bDMARDs Improve Vascular Function in Treatment-naïve Patients with Early Rheumatoid Arthritis

Early Knee, Jaw, Wrist, or Elbow Swelling Associated with Worse Rheumatoid Arthritis Prognosis

Once Stable, Many Decompensated Heart Failure Patients Can Be Initiated on Life-Saving Medication

JAK Inhibitors Test Specificity of Action in Rheumatoid Arthritis

Psoriatic Arthritis Remains Controlled on Anti-IL-17 Agents out to Three Years

Ensuring that All Heart Failure Patients Receive Optimal Treatment

In COPD, Large Percentage of Clinicians Ignore Evidence-based Guidelines

Phase 3 Trials of As-needed Anti-inflammatory Regimen Tested in Mild Asthma

Polycythaemia Vera: JAK Inhibition after Hydroxyurea Resistance

Myelofibrosis: Survival and Quality of Life Benefits from Early Intervention

Emerging Options: Moving Toward JAK1 Selectivity in Rheumatoid Arthritis